Bone & Joint

A Henry Ford Hospital study finds women with Type 2 diabetes who take a commonly prescribed class of medications called TZD’s to treat insulin resistance may be at a higher risk for developing bone fractures within 1 year of taking the medication.…

A research team led by a Michigan State University professor has discovered a link between diabetes and bone marrow nerve damage that may help treat one of the disease’s most common and potentially blindness-causing complications.

Diabetic patients with poor control of blood glucose face an increased risk of post-surgical complications and death following total hip or knee arthroplasty, according to a new study.

Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions, but those complications are less likely to occur when a diabetic patient has glucose levels under control.

Dr. Aaron Vinik, principle investigator for the study at Eastern Virginia Medical School in Norfolk, is testing a new diabetes drug, Prochymal.  It’s part of a first-of-its-kind study for finding a possible cure.

Lead author Claudia Sedlinsky, MD, of GIOMM – La Plata National University, La Plata, Buenos Aires, Argentina stated that, both metformin and rosiglitazone are widely used in the treatment of Type 2 diabetes and metabolic syndrome. 

The largest study to date looking at whether the risk of bone fractures is increased in the setting of thiazolidinedione drugs (TZDs) suggests that fracture risk is more than 40% higher in people taking TZDs and that both men and women are vulnerable 

Researchers have found that transplanting cells that replenish blood vessels can also restore nerve function in an animal model of diabetic neuropathy.

Long-term use of a class of drugs for type 2 diabetes doubles a woman’s risk of breaking a bone, research suggests.

People with type 1 diabetes who undergo total hip or knee replacement generally fare worse than people with type 2 diabetes, who in turn do worse than non-diabetic patients, according to study findings.